Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

[Osteogenic and adipogenic differentiation of bone marrow multipotent mesenchymal stem cells in the mice with hemorrhagic anemia].

Wu MQ, Zhu RJ, Liu KY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Feb;22(1):177-82. doi: 10.7534/j.issn.1009-2137.2014.01.034. Chinese.

PMID:
24598673
2.

Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.

Gambardella A, Nagaraju CK, O'Shea PJ, Mohanty ST, Kottam L, Pilling J, Sullivan M, Djerbi M, Koopmann W, Croucher PI, Bellantuono I.

J Bone Miner Res. 2011 Apr;26(4):811-21. doi: 10.1002/jbmr.266.

3.

A novel PPARγ2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiation.

Kim J, Ko J.

Cell Death Differ. 2014 Oct;21(10):1642-55. doi: 10.1038/cdd.2014.80. Epub 2014 Jun 20.

4.

Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes.

Biver G, Wang N, Gartland A, Orriss I, Arnett TR, Boeynaems JM, Robaye B.

Stem Cells. 2013 Dec;31(12):2747-58. doi: 10.1002/stem.1411.

5.

Epigenetic Plasticity Drives Adipogenic and Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells.

Meyer MB, Benkusky NA, Sen B, Rubin J, Pike JW.

J Biol Chem. 2016 Aug 19;291(34):17829-47. doi: 10.1074/jbc.M116.736538. Epub 2016 Jul 11.

6.

Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation.

Ghali O, Broux O, Falgayrac G, Haren N, van Leeuwen JP, Penel G, Hardouin P, Chauveau C.

BMC Cell Biol. 2015 Mar 13;16:9. doi: 10.1186/s12860-015-0056-6.

8.

Climbing exercise enhances osteoblast differentiation and inhibits adipogenic differentiation with high expression of PTH/PTHrP receptor in bone marrow cells.

Menuki K, Mori T, Sakai A, Sakuma M, Okimoto N, Shimizu Y, Kunugita N, Nakamura T.

Bone. 2008 Sep;43(3):613-20. doi: 10.1016/j.bone.2008.04.022. Epub 2008 May 9.

PMID:
18567552
9.

Heparin affects human bone marrow stromal cell fate: Promoting osteogenic and reducing adipogenic differentiation and conversion.

Simann M, Schneider V, Le Blanc S, Dotterweich J, Zehe V, Krug M, Jakob F, Schilling T, Schütze N.

Bone. 2015 Sep;78:102-13. doi: 10.1016/j.bone.2015.04.039. Epub 2015 May 7.

PMID:
25959412
10.

Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts.

Cheng H, Qiu L, Ma J, Zhang H, Cheng M, Li W, Zhao X, Liu K.

Mol Biol Rep. 2011 Nov;38(8):5161-8. doi: 10.1007/s11033-010-0665-2. Epub 2010 Dec 29.

PMID:
21188535
11.

Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation.

Nishikawa K, Nakashima T, Takeda S, Isogai M, Hamada M, Kimura A, Kodama T, Yamaguchi A, Owen MJ, Takahashi S, Takayanagi H.

J Clin Invest. 2010 Oct;120(10):3455-65. doi: 10.1172/JCI42528. Epub 2010 Sep 27.

12.

Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling.

Saidak Z, Haÿ E, Marty C, Barbara A, Marie PJ.

Aging Cell. 2012 Jun;11(3):467-74. doi: 10.1111/j.1474-9726.2012.00804.x. Epub 2012 Mar 12.

13.

Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.

Lee NJ, Doyle KL, Sainsbury A, Enriquez RF, Hort YJ, Riepler SJ, Baldock PA, Herzog H.

J Bone Miner Res. 2010 Aug;25(8):1736-47. doi: 10.1002/jbmr.61.

14.

Adipocytes derived from human bone marrow mesenchymal stem cells exert inhibitory effects on osteoblastogenesis.

Zhang H, Lu W, Zhao Y, Rong P, Cao R, Gu W, Xiao J, Miao D, Lappe J, Recker R, Xiao GG.

Curr Mol Med. 2011 Aug;11(6):489-502.

PMID:
21663588
15.

Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells.

Casado-Díaz A, Santiago-Mora R, Dorado G, Quesada-Gómez JM.

Arch Med Res. 2013 Jul;44(5):325-34. doi: 10.1016/j.arcmed.2013.05.002. Epub 2013 Jul 16.

PMID:
23867791
16.

Methotrexate chemotherapy reduces osteogenesis but increases adipogenic potential in the bone marrow.

Georgiou KR, Scherer MA, Fan CM, Cool JC, King TJ, Foster BK, Xian CJ.

J Cell Physiol. 2012 Mar;227(3):909-18. doi: 10.1002/jcp.22807.

PMID:
21503894
17.

Quantitative approaches to detect donor and passage differences in adipogenic potential and clonogenicity in human bone marrow-derived mesenchymal stem cells.

Lo Surdo J, Bauer SR.

Tissue Eng Part C Methods. 2012 Nov;18(11):877-89. doi: 10.1089/ten.TEC.2011.0736. Epub 2012 Jun 25.

18.

Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression.

Huang S, Wang S, Bian C, Yang Z, Zhou H, Zeng Y, Li H, Han Q, Zhao RC.

Stem Cells Dev. 2012 Sep 1;21(13):2531-40. doi: 10.1089/scd.2012.0014. Epub 2012 Apr 2.

19.

Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.

Guang LG, Boskey AL, Zhu W.

Int J Biochem Cell Biol. 2013 Aug;45(8):1813-20. doi: 10.1016/j.biocel.2013.05.034. Epub 2013 Jun 4.

PMID:
23742988
20.

Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells.

Jarocha D, Lukasiewicz E, Majka M.

Folia Histochem Cytobiol. 2008;46(3):307-14. doi: 10.2478/v10042-008-0046-z.

Supplemental Content

Support Center